Pet Diabetes Care Market Share, Size, Trends, Analysis, Competition and Future Investment Till 2034
Pet Diabetes Care Market Growth, Size, Trends Analysis - By Animal Type, By Solution, By Distribution Channel - Regional Outlook, Competitive Strategies and Segment Forecast to 2034
| Published: Mar-2025 | Report ID: HLCA2594 | Pages: 1 - 247 | Formats*: |
| Category : Healthcare | |||
Pet Diabetes Care Market Introduction and Overview
According to SPER Market Research, the Global Pet Diabetes Care Market is estimated to reach USD 5.06 billion by 2034 with a CAGR of 9.19%.
The report includes an in-depth analysis of the Global Pet Diabetes Care Market, including market size and trends, product mix, Applications, and supplier analysis.
The increasing incidence of diabetes in pets, which is fueled by factors like obesity, aging pet populations, and genetic susceptibility, is driving growth in the pet diabetes treatment market. Further propelling market expansion include rising pet ownership rates, increased knowledge of pet health, and improvements in veterinary diagnostics and treatment choices, such as insulin therapy and glucose monitoring equipment. Continuous glucose monitoring systems are one example of a technological advancement that improves illness management. However, obstacles to growth include the high expense of diabetes care, a lack of knowledge in developing nations, and issues with pet owners adhering to treatment plans.
By Animal Type Insights: Pet Diabetes Care is classified into two categories based on Animal Type: Dogs, Cats. According to animal kind, the dog category led the market. Global dog ownership is the main factor driving this segment. The cat market is expected to grow at a compound annual growth rate (CAGR) over the course of the forecast period as pet owners become more aware of the symptoms of diabetes in their felines.
By Solution Insights: The market for Pet Diabetes Care is segmented based on Solution, including Treatment, Glucose Monitoring Devices. The market share was highest in the treatment segment. The gold standard for treating diabetes in companions, according to vets, is insulin therapy, which facilitates the movement of glucose from food into other parts of the body. Due to manufacturers introducing diabetes care equipment for companions and the growing number of companions acquiring a diabetes diagnosis, the glucose monitoring devices sector is anticipated to have a large market share over the forecast period.
By Distribution Channel Insights: The market for Pet Diabetes Care is divided based on Distribution Channel, including Veterinary Hospitals & Clinics, Retail Pharmacies and E-Commerce. The biggest market share was held by the veterinary clinics and hospitals segment. This is because there are more and more modern veterinary clinics and hospitals. Over the course of the projected period, the e-commerce segment is expected to develop at the quickest CAGR. Insulin, syringes, glucose meters, and other diabetes management supplies are now more easily accessible to companion owners thanks to the growth of internet commerce.
By Regional Insights: The market for diabetes care for pets is mostly dominated by North America. This is brought on by the high incidence of diabetes in pets, rising costs for pet care, and sophisticated veterinary facilities. Market domination is further fueled by the region's high pet owner knowledge and the accessibility of cutting-edge diabetes care solutions.
Market Competitive Landscape
The market is competitive, and the leading businesses are putting a variety of strategic initiatives into practice, such as mergers and acquisitions, competitive pricing, partnerships and collaboration, and sales and marketing campaigns. Some of the key market players are BD, Boehringer Ingelheim International GmbH, Merck Animal Health, Nova Biomedical, Zoetis, Allison Medical, Inc., UltiMed, Inc., AccuBioTech Co., Ltd, I-SENS, Inc., TaiDoc Technology Corporation.
Recent Developments:
- In December 2023, Willows developed a clinic focused on diabetes mellitus in cats and dogs. Helping pets with diabetes, both newly diagnosed and chronic, is the clinic's main objective, especially when clinical progress or decision-making has proven difficult.
- In August 2023, the ground-breaking new drug SENVELGO, developed by Boehringer Ingelheim, has been approved by the U.S. Food and Drug Administration for usage by cats with diabetes.
Scope of the Report:
| Report Metric | Details |
| Market size available for years | 2021-2034 |
| Base year considered | 2024 |
| Forecast period | 2025-2034 |
| Segments covered | By Animal Type, By Solution, By Distribution Channel. |
| Regions covered | North America, Latin America, Asia-Pacific, Europe, and Middle East & Africa. |
| Companies Covered | BD, Boehringer Ingelheim International GmbH, Merck Animal Health, Nova Biomedical, Zoetis, Allison Medical, Inc., UltiMed, Inc., AccuBioTech Co., Ltd, I-SENS, Inc., TaiDoc Technology Corporation. |
Key Topics Covered in the Report
- Global Pet Diabetes Care Market Size (FY’2021-FY’2034)
- Overview of Global Pet Diabetes Care Market
- Segmentation of Global Pet Diabetes Care Market By Animal Type (Dogs, Cats)
- Segmentation of Global Pet Diabetes Care Market By Solution (Treatment, Glucose Monitoring Devices)
- Segmentation of Global Pet Diabetes Care Market By Distribution Channel (Veterinary Hospitals & Clinics, Retail Pharmacies, E-Commerce)
- Statistical Snap of Global Pet Diabetes Care Market
- Expansion Analysis of Global Pet Diabetes Care Market
- Problems and Obstacles in Global Pet Diabetes Care Market
- Competitive Landscape in the Global Pet Diabetes Care Market
- Details on Current Investment in Global Pet Diabetes Care Market
- Competitive Analysis of Global Pet Diabetes Care Market
- Prominent Players in the Global Pet Diabetes Care Market
- SWOT Analysis of Global Pet Diabetes Care Market
- Global Pet Diabetes Care Market Future Outlook and Projections (FY’2025-FY’2034)
- Recommendations from Analyst
1. Introduction
1.1. Scope of the report1.2. Market segment analysis
2. Research Methodology
2.1. Research data source
2.1.1. Secondary Data2.1.2. Primary Data2.1.3. SPERs internal database2.1.4. Premium insight from KOLs
2.2. Market size estimation
2.2.1. Top-down and Bottom-up approach
2.3. Data triangulation
3. Executive Summary
4. Market Dynamics
4.1. Driver, Restraint, Opportunity and Challenges analysis
4.1.1. Drivers4.1.2. Restraints4.1.3. Opportunities4.1.4. Challenges
5. Market variable and outlook
5.1. SWOT Analysis
5.1.1. Strengths5.1.2. Weaknesses5.1.3. Opportunities5.1.4. Threats
5.2. PESTEL Analysis
5.2.1. Political Landscape5.2.2. Economic Landscape5.2.3. Social Landscape5.2.4. Technological Landscape5.2.5. Environmental Landscape5.2.6. Legal Landscape
5.3. PORTERs Five Forces
5.3.1. Bargaining power of suppliers5.3.2. Bargaining power of buyers5.3.3. Threat of Substitute5.3.4. Threat of new entrant5.3.5. Competitive rivalry
5.4. Heat Map Analysis
6. Competitive Landscape
6.1. Global Pet Diabetes Care Market Manufacturing Base Distribution, Sales Area, Product Type6.2. Mergers & Acquisitions, Partnerships, Product Launch, and Collaboration in Global Pet Diabetes Care Market
7. Global Pet Diabetes Care Market, By Animal Type 2021-2034 (USD Million)
7.1. Dogs7.2. Cats
8. Global Pet Diabetes Care Market, By Solution 2021-2034 (USD Million)
8.1. Treatment
8.1.1. Insulin Therapy8.1.2. Insulin Delivery Devices8.1.3. Other Treatments
8.2. Glucose Monitoring Devices
9. Global Pet Diabetes Care Market, By Distribution Channel 2021-2034 (USD Million)
9.1. Veterinary Hospitals & Clinics9.2. Retail Pharmacies9.3. E-Commerce
10. Global Pet Diabetes Care Market, 2021-2034 (USD Million)
10.1. Global Pet Diabetes Care Market Size and Market Share
11. Global Pet Diabetes Care Market, By Region, 2021-2034 (USD Million)
11.1. Asia-Pacific
11.1.1. Australia11.1.2. China11.1.3. India11.1.4. Japan11.1.5. South Korea11.1.6. Rest of Asia-Pacific
11.2. Europe
11.2.1. France11.2.2. Germany11.2.3. Italy11.2.4. Spain11.2.5. United Kingdom11.2.6. Rest of Europe
11.3. Middle East and Africa
11.3.1. Kingdom of Saudi Arabia11.3.2. United Arab Emirates11.3.3. Qatar11.3.4. South Africa11.3.5. Egypt11.3.6. Morocco11.3.7. Nigeria11.3.8. Rest of Middle-East and Africa
11.4. North America
11.4.1. Canada11.4.2. Mexico11.4.3. United States
11.5. Latin America
11.5.1. Argentina11.5.2. Brazil11.5.3. Rest of Latin America
12. Company Profile
12.1. AccuBioTech Co, Ltd
12.1.1. Company details12.1.2. Financial outlook12.1.3. Product summary12.1.4. Recent developments
12.2. Allison Medical, Inc.
12.2.1. Company details12.2.2. Financial outlook12.2.3. Product summary12.2.4. Recent developments
12.3. BD
12.3.1. Company details12.3.2. Financial outlook12.3.3. Product summary12.3.4. Recent developments
12.4. Boehringer Ingelheim International Gmbh.
12.4.1. Company details12.4.2. Financial outlook12.4.3. Product summary12.4.4. Recent developments
12.5. I-SENS, Inc
12.5.1. Company details12.5.2. Financial outlook12.5.3. Product summary12.5.4. Recent developments
12.6. Merck Animal Health.
12.6.1. Company details12.6.2. Financial outlook12.6.3. Product summary12.6.4. Recent developments
12.7. Nova Biomedical
12.7.1. Company details12.7.2. Financial outlook12.7.3. Product summary12.7.4. Recent developments
12.8. Taidoc Technology Corporation.
12.8.1. Company details12.8.2. Financial outlook12.8.3. Product summary12.8.4. Recent developments
12.9. Ultimed, Inc.
12.9.1. Company details12.9.2. Financial outlook12.9.3. Product summary12.9.4. Recent developments
12.10. Zoetis
12.10.1. Company details12.10.2. Financial outlook12.10.3. Product summary12.10.4. Recent developments
12.11. Others
13. Conclusion
14. List of Abbreviations
15. Reference Links
SPER Market Research’s methodology uses great emphasis on primary research to ensure that the market intelligence insights are up to date, reliable and accurate. Primary interviews are done with players involved in each phase of a supply chain to analyze the market forecasting. The secondary research method is used to help you fully understand how the future markets and the spending patterns look likes.
The report is based on in-depth qualitative and quantitative analysis of the Product Market. The quantitative analysis involves the application of various projection and sampling techniques. The qualitative analysis involves primary interviews, surveys, and vendor briefings. The data gathered as a result of these processes are validated through experts opinion. Our research methodology entails an ideal mixture of primary and secondary initiatives.
Frequently Asked Questions About This Report
Pet Diabetes Care Market is projected to reach USD 5.06 billion by 2034, growing at a CAGR of 9.19% during the forecast period.
Pet Diabetes Care Market grew in Market size from 2025. The Market is expected to reach USD 5.06 billion by 2034, at a CAGR of 9.19% during the forecast period.
Pet Diabetes Care Market CAGR of 9.19% during the forecast period.
You can get the sample pages by clicking the link - Click Here
Pet Diabetes Care Market size is USD 5.06 billion from 2025 to 2034.
Pet Diabetes Care Market is covered By Product, By Function, By Application, By End-User.
The North America is anticipated to have the highest Market share in the Pet Diabetes Care Market.
The key players in the Market include Companies Covered BD, Boehringer Ingelheim International GmbH, Merck Animal Health, Nova Biomedical, Zoetis, Allison Medical, Inc., UltiMed, Inc., AccuBioTech Co., Ltd, I-SENS, Inc., TaiDoc Technology Corporation.
The increasing incidence of diabetes in pets, which is fueled by factors like obesity, aging pet populations, and genetic susceptibility, is driving growth in the pet diabetes treatment market. Further propelling market expansion include rising pet ownership rates, increased knowledge of pet health, and improvements in veterinary diagnostics and treatment choices, such as insulin therapy and glucose monitoring equipment.
PLACE AN ORDER
Year End Discount
Sample Report
Pre-Purchase Inquiry
NEED CUSTOMIZATION?
Request CustomizationCALL OR EMAIL US
100% Secure Payment
Related Reports
Have a glance of the Report
Our Global Clients
Our data-driven insights have influenced the strategy of 200+ reputed companies across the globe.
